Paradigm Asset Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,550
| Closed | -$45K | – | 606 |
|
|
2017
Q1 | $45K | Sell |
1,550
-24,050
| -94% | -$698K | 0.01% | 578 |
|
|
2016
Q4 | $841K | Sell |
25,600
-9,600
| -27% | -$315K | 0.16% | 113 |
|
|
2016
Q3 | $1.11M | Buy |
35,200
+13,550
| +63% | +$427K | 0.19% | 101 |
|
|
2016
Q2 | $609K | Buy |
21,650
+15,400
| +246% | +$433K | 0.11% | 195 |
|
|
2016
Q1 | $227K | Sell |
6,250
-6,800
| -52% | -$247K | 0.04% | 300 |
|
|
2015
Q4 | $522K | Buy |
13,050
+100
| +0.8% | +$4K | 0.09% | 206 |
|
|
2015
Q3 | $369K | Buy |
+12,950
| New | +$369K | 0.05% | 342 |
|